Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 28, 2021; 27(48): 8302-8322
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Primer | Product size | Sequence (5’-3’) |
VAMP2 (NM_001330125.1) | 182 bp | F-GGTCTCTCCTGCGTTCCC |
R-TCGACCCGAAAAGACAGGC | ||
GAPDH (NM_002046.7) | 197 bp | F-GGAGCGAGATCCCTCCAAAAT |
R-GGCTGTTGTCATACTTCTCATGG | ||
U6 (NR_004394.1) | 94 bp | F-CTCGCTTCGGCAGCACA |
R-AACGCTTCACGAATTTGCGT | ||
miR135a (NR_029677.1) | 68 bp | F-ACACTCCAGCTGGGTATGGCTTTTTATTCCT |
R-TGGTGTCGTGGAGTCG |
- Citation: Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322
- URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8302